+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome



Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome



Alimentary Pharmacology & Therapeutics 14(7): 869-878



Background: Alosetron, a 5-HT3-receptor antagonist, relieves abdominal pain and improves bowel function in non-constipated, female patients with irritable bowel syndrome. 5-HT3 antagonists delay colonic transit, increase colonic compliance, and increase small intestinal water absorption. Aim: To evaluate the effects of alosetron on gastrointestinal and colonic transit, rectal compliance and rectal sensation in irritable bowel syndrome. Methods: A double-blind, placebo-controlled, two-dose study of alosetron was performed in 25 non-constipated irritable bowel syndrome patients, with paired studies before and after 4 weeks of treatment with placebo (n = 5), 1 mg alosetron (n = 10) or 4 mg (n = 10) alosetron b.d. Gastrointestinal and colonic transit were measured by scintigraphy. Rectal compliance and sensation were assessed by rectal balloon distention with a barostat. Results: There was a trend (P = 0.06) for 1 mg alosetron to increase rectal compliance (median pressure at half maximum volume 11 mmHg after alosetron vs. 15.6 mmHg before alosetron). The 1 mg b.d. alosetron dose non-significantly retarded proximal colonic transit. Alosetron and placebo reduced sensory scores relative to baseline values; none of the changes induced by alosetron was significant relative to placebo. Conclusions: Alosetron had no significant effect on gastrointestinal transit or rectal sensory and motor mechanisms in non-constipated irritable bowel syndrome patients in this study. Alosetron's effects on colonic sensorimotor function and central sensory mechanisms deserve further evaluation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010544954

Download citation: RISBibTeXText

PMID: 10886042

DOI: 10.1046/j.1365-2036.2000.00786.x


Related references

Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 3(3): 267-276, 1989

Alosetron slows colonic transit in patients with irritable bowel syndrome. Gastroenterology 112(4 Suppl. ): A732, 1997

Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Alimentary Pharmacology & Therapeutics 14(6): 775-782, 2000

Effects of Chili Treatment on Gastrointestinal and Rectal Sensation in Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blinded, Crossover Study. Journal of Neurogastroenterology and Motility 20(3): 400-406, 2014

Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome. Gastroenterology 118(4 Suppl 2 Part 1): AGA A848, 2000

S1302 Dose-Related Effects of Chenodeoxycholate on Gastrointestinal and Colonic Transit and Bowel Function in Female Patients With Constipation-Predominant Irritable Bowel Syndrome. Gastroenterology 138(5): S-224, 2010

T1405 Effects of a Novel Corticotrophin Releasing Factor Receptor-1 Antagonist, Bms-562086, On Gastrointestinal and Colonic Transit and Bowel Habits in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (D-Ibs). Gastroenterology 134(4): A-548, 2008

S1261 Colonic Transit Time Influences the Abnormal Bowel Habit, But Not Other Gastrointestinal Symptoms, in Irritable Bowel Syndrome. Gastroenterology 136(5): A-224, 2009

Anorectal manometry and rectal sensation in patients with the irritable bowel syndrome. Gastroenterologypart 2: A450, 1988

Gastrointestinal transit in patients with irritable bowel syndrome. Gastroenterology 106(4 Suppl. ): A512, 1994

Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder. Drugs 63(18): 1895-1905, 2003

Effects of oral cimetropium bromide cb on intestinal transit time in irritable bowel syndrome patients. Gastroenterology 92(5 Part 2): 1567, 1987

A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 22(1): 69-77, 2016

The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome. Neurogastroenterology and Motility 17(2): 212-221, 2005

Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?. Techniques in Coloproctology 10(4): 287-296, 2006